1-6 of 6
half-life
Close
Sort by
Journal Articles

New therapies for hemophilia

Steven W. Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 650–656.
https://doi.org/10.1182/asheducation-2016.1.650
Published: 2016
Journal Articles

What is the role of an extended half-life product in immune tolerance induction in a patient with severe hemophilia A and high-titer inhibitors?

Maissaa Janbain, Steven Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 648–649.
https://doi.org/10.1182/asheducation-2016.1.648
Published: 2016
Journal Articles

The long and short of it: using the new factor products

Amy Dunn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 26–32.
https://doi.org/10.1182/asheducation-2015.1.26
Published: 2015
Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.
https://doi.org/10.1182/asheducation-2013.1.44
Published: 2013
Journal Articles

Biological Rationale for New Drugs in the Bleeding Disorders Pipeline

Patrick F. Fogarty
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 397–404.
https://doi.org/10.1182/asheducation-2011.1.397
Published: 2011
Journal Articles

Hemophilia: New Protein Therapeutics

Steven W. Pipe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 203–209.
https://doi.org/10.1182/asheducation-2010.1.203
Published: 2010